cysteine has been researched along with Diabetic Glomerulosclerosis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Jin, X; Wang, X; Wang, Y; Wu, L; Xing, X; Yang, W; Yang, Z; Zhang, B; Zhang, J; Zhang, X | 1 |
| Brahmanaidu, P; Ravindarnaik, R; Saravanan, G; Sathibabu Uddandrao, VV; Suresh, P; Vadivukkarasi, S | 1 |
| Antunes, AMM; Coelho, NR; Correia, MJ; Gonçalves-Dias, C; Macedo, MP; Monteiro, EC; Morello, J; Pereira, SA; Soto, K | 1 |
| Ge, R; Li, X; Luo, S; Ma, F; Qian, X; Zhu, Y | 1 |
| Hu, P; Jiang, Z; Li, P; Liang, Q; Luo, G; Wang, Y | 1 |
| Bull, R; Croad, JL; Jain, SK; Rains, JL; Velusamy, T | 1 |
| Mong, MC; Yin, MC | 1 |
| Bàràny, P; Bergström, J; Heimbürger, O; Lindholm, B; Stenvinkel, P; Suliman, ME | 1 |
| Buraczyńska, M; Ksiazek, A; Ksiazek, P; Nowicka, T; Spasiewicz, D; Łopatyński, J | 1 |
| Fowler, B; Herrmann, W; Kuhlmann, MK; Makowski, J; Obeid, R; Schorr, H | 1 |
| Balkau, B; Besmond, C; Danze, PM; Fajardy, I; Fontaine, P; Marre, M; Prevost, G; Tichet, J | 1 |
| Dnyanmote, AV; Latendresse, JR; Lock, EA; Mehendale, HM; Sawant, SP; Warbritton, AA | 1 |
| Chiang, PF; Hsu, CC; Wu, WJ; Yin, MC | 1 |
| Bodalski, J; Frieske, I; Gadzicki, M; Kuśmierek, J; Rogozińska-Zawiślak, A; Surma, MJ; Szadkowska, A | 1 |
1 review(s) available for cysteine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Mercapturate Pathway in the Tubulocentric Perspective of Diabetic Kidney Disease.
Topics: Acetylcysteine; Acetyltransferases; Cysteine; Diabetic Nephropathies; Humans; Kidney Tubules, Proximal; Leukotrienes; Oxidative Stress | 2019 |
13 other study(ies) available for cysteine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Development and assessment of diabetic nephropathy prediction model using hub genes identified by weighted correlation network analysis.
Topics: Cysteine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hormones; Humans; Methionine; Polysaccharides; Retrospective Studies | 2022 |
Restorative potentiality of S-allylcysteine against diabetic nephropathy through attenuation of oxidative stress and inflammation in streptozotocin-nicotinamide-induced diabetic rats.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cysteine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Inflammation; Male; Niacinamide; Oxidative Stress; Rats; Rats, Wistar; Streptozocin | 2019 |
Novel hydrogen sulfide-releasing compound, S-propargyl-cysteine, prevents STZ-induced diabetic nephropathy.
Topics: Animals; Cell Proliferation; Cell Size; Cells, Cultured; Cysteine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Matrix; Hydrogen Sulfide; Kidney; Male; MAP Kinase Signaling System; Mesangial Cells; Nephritis; Rats, Sprague-Dawley; Smad3 Protein; Transforming Growth Factor beta1 | 2016 |
HPLC-electrospray tandem mass spectrometry for simultaneous quantitation of eight plasma aminothiols: application to studies of diabetic nephropathy.
Topics: Calibration; Case-Control Studies; Chromatography, High Pressure Liquid; Cysteine; Diabetic Nephropathies; Drug Evaluation, Preclinical; Humans; Ions; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Sulfhydryl Compounds; Tandem Mass Spectrometry; Time Factors | 2009 |
Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats.
Topics: Adiponectin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Biomarkers; Cell Line; Chromium; Coordination Complexes; Cysteine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Dietary Supplements; Humans; Hypoglycemic Agents; Liver; Male; Monocytes; Organometallic Compounds; Oxidative Stress; Random Allocation; Rats; Rats, Zucker; Signal Transduction | 2010 |
Nuclear factor κB-dependent anti-inflammatory effects of s-allyl cysteine and s-propyl cysteine in kidney of diabetic mice.
Topics: Animals; Anti-Inflammatory Agents; Cysteine; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dinoprostone; Kidney; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide; Reactive Oxygen Species | 2012 |
Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
Topics: Adult; Amino Acids, Sulfur; Cardiovascular Diseases; Cross-Sectional Studies; Cysteine; Deficiency Diseases; Diabetic Nephropathies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Nutrition Assessment; Nutrition Disorders; Nutritional Status; Prevalence; Protein-Energy Malnutrition; Renal Dialysis; Serum Albumin | 2002 |
[Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes].
Topics: Adult; Alanine; Alleles; Angiotensinogen; Case-Control Studies; Cysteine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Genotype; Humans; Male; Methionine; Middle Aged; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin-Angiotensin System; Threonine | 2002 |
Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes.
Topics: Aged; Cystathionine; Cysteine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Folic Acid; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Male; Methionine; Methylmalonic Acid; Middle Aged; S-Adenosylhomocysteine; S-Adenosylmethionine; Transcobalamins; Vitamin B 12; Vitamin B 6 | 2005 |
Polymorphisms of the receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients.
Topics: Amino Acid Substitution; Arginine; Cross-Sectional Studies; Cysteine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Exons; Female; Genotype; Glycine; Humans; Male; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Serine | 2005 |
Diabetic mice are protected from normally lethal nephrotoxicity of S-1,2-dichlorovinyl-L-cysteine (DCVC): role of nephrogenic tissue repair.
Topics: Animals; Area Under Curve; Blood Urea Nitrogen; Bromodeoxyuridine; Cell Nucleus; Colchicine; Creatinine; Cysteine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Half-Life; Immunohistochemistry; Injections, Intraperitoneal; Kidney Tubules, Proximal; Lyases; Male; Mice; Proliferating Cell Nuclear Antigen; Regeneration; S Phase; Streptozocin; Thymidine; Tritium | 2006 |
Antiinflammatory and antifibrogenic effects of s-ethyl cysteine and s-methyl cysteine in the kidney of diabetic mice.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents; Antioxidants; Collagen Type IV; Cysteine; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drinking; Fibrosis; Glutathione; Kidney; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Weight Loss | 2007 |
Parametric clearance kidney scintigrams; diagnostic potential in diabetes.
Topics: Adolescent; Adult; Child; Cysteine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Kidney; Male; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Renal Blood Flow, Effective | 2007 |